Stryker Orthopaedics Settlement Program Reaches Milestone - 95% of Registered Eligible U.S. Patients Enrolled in Program #stryker / #strykerhip / #strykersettlement / #hiprecall

Howmedica Osteonics Corp. (referred to as “Stryker Orthopaedics”), a subsidiary of Stryker Corporation has informed the courts in the New Jersey Multicounty and Federal Multidistrict litigations that 95% of registered eligible patients have enrolled in the Settlement Program under the Master Settlement Agreement announced in November 2014. As a result, Stryker Orthopaedics will move forward with the Settlement Program.

The base settlement award for each Plaintiff is $300,000 per hip revision surgery. The settlement program also pays for revision surgery and reduces any medical provider liens, such as Medicare through the settlement of all liens as part of the program.

The Stryker Master Settlement Agreement was established to compensate eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck hip stem and/or ABG II Modular-Neck hip stem, known as a revision surgery. Shortly, the Claims Processor will begin notifying claimants and their attorneys regarding compensation payments, the exact timing and amount of payments will depend on factors and circumstances specific to each claim. It is expected that payments will begin this July and the majority of payments will be made by the fall of 2015.

If you have had a Stryker hip implant, you may qualify to participate in the Settlement Program, regardless of whether you’ve had revision surgery. Other hip implants are also effected through recalls. If you have had hip surgery, contact The Ahearne Law Firm, PLLC for a free consultation.